| Year |
Citation |
Score |
| 2023 |
Ertl HCJ. Circumventing B Cell Responses to Allow for Redosing of Adeno-Associated Virus Vectors. Human Gene Therapy. PMID 37861281 DOI: 10.1089/hum.2023.162 |
0.311 |
|
| 2023 |
Afkhami S, D'Agostino MR, Vaseghi-Shanjani M, Lepard M, Yang JX, Lai R, Choi MWY, Chacon A, Zganiacz A, Franken KLMC, Ertl HC, Ottenhoff THM, Jeyanathan M, Gillgrass A, Xing Z. Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice. Npj Vaccines. 8: 25. PMID 36823425 DOI: 10.1038/s41541-023-00623-z |
0.506 |
|
| 2023 |
Ertl HCJ. Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression. Drugs. PMID 36715794 DOI: 10.1007/s40265-023-01836-1 |
0.347 |
|
| 2022 |
Hasanpourghadi M, Novikov M, Ambrose R, Chekaoui A, Newman D, Ding J, Giles-Davis W, Xiang Z, Zhou XY, Liu Q, Swagata K, Ertl HC. Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19. Microbes and Infection. 105082. PMID 36539010 DOI: 10.1016/j.micinf.2022.105082 |
0.467 |
|
| 2022 |
Ertl HCJ, Currie SL, Luber AD. Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health. Frontiers in Immunology. 13: 985382. PMID 36091063 DOI: 10.3389/fimmu.2022.985382 |
0.343 |
|
| 2022 |
Ertl HCJ. Immunogenicity and toxicity of AAV gene therapy. Frontiers in Immunology. 13: 975803. PMID 36032092 DOI: 10.3389/fimmu.2022.975803 |
0.329 |
|
| 2022 |
Jenkin D, Ritchie AJ, Aboagye J, Fedosyuk S, Thorley L, Provstgaad-Morys S, Sanders H, Bellamy D, Makinson R, Xiang ZQ, Bolam E, Tarrant R, Ramos Lopez F, Platt A, Poulton I, ... ... Ertl HCJ, et al. Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial. The Lancet. Microbe. PMID 35907430 DOI: 10.1016/S2666-5247(22)00126-4 |
0.343 |
|
| 2022 |
Hasanpourghadi M, Novikov M, Ambrose R, Chekaoui A, Newman D, Zhou XY, Ertl HCJ. T cell responses to adenoviral vectors expressing the SARS-CoV-2 nucleoprotein. Current Trends in Microbiology. 15: 1-28. PMID 35903088 |
0.59 |
|
| 2022 |
Herati RS, Knorr DA, Vella LA, Silva LV, Chilukuri L, Apostolidis SA, Huang AC, Muselman A, Manne S, Kuthuru O, Staupe RP, Adamski SA, Kannan S, Kurupati RK, Ertl HCJ, et al. PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. Nature Immunology. 23: 1183-1192. PMID 35902637 DOI: 10.1038/s41590-022-01274-3 |
0.383 |
|
| 2022 |
Ertl HCJ, Currie SL, Livermore DM. Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19? Frontiers in Public Health. 10: 929445. PMID 35769785 DOI: 10.3389/fpubh.2022.929445 |
0.324 |
|
| 2022 |
Logunov DY, Livermore DM, Ornelles DA, Bayer W, Marques E, Czerkinsky C, Dolzhikova IV, Ertl HC. COVID-19 vaccination and HIV-1 acquisition. Lancet (London, England). 399: e34-e35. PMID 35397866 DOI: 10.1016/S0140-6736(22)00332-4 |
0.328 |
|
| 2022 |
Xiang Z, Kuranda K, Quinn W, Chekaoui A, Ambrose R, Hasanpourghadi M, Novikov M, Newman D, Cole C, Zhou X, Mingozzi F, Ertl HCJ. The effect of rapamycin and ibrutinib on antibody responses to adeno-associated virus vector-mediated gene transfer. Human Gene Therapy. PMID 35229644 DOI: 10.1089/hum.2021.258 |
0.39 |
|
| 2021 |
Hasanpourghadi M, Novikov M, Newman D, Xiang Z, Zhou XY, Magowan C, Ertl HCJ. Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection. Virology Journal. 18: 242. PMID 34876153 DOI: 10.1186/s12985-021-01712-y |
0.322 |
|
| 2021 |
Chekaoui A, Ertl HCJ. PPARa agonist fenofibrate enhances cancer vaccine efficacy. Cancer Research. PMID 34244236 DOI: 10.1158/0008-5472.CAN-21-0052 |
0.367 |
|
| 2021 |
Chekaoui A, Ertl HCJ. PPARa agonist fenofibrate enhances cancer vaccine efficacy. Cancer Research. PMID 34244236 DOI: 10.1158/0008-5472.CAN-21-0052 |
0.367 |
|
| 2021 |
Herati RS, Silva LV, Vella LA, Muselman A, Alanio C, Bengsch B, Kurupati RK, Kannan S, Manne S, Kossenkov AV, Canaday DH, Doyle SA, Ertl HCJ, Schmader KE, Wherry EJ. Vaccine-induced ICOSCD38 circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways. Cell Reports. Medicine. 2: 100262. PMID 34095875 DOI: 10.1016/j.xcrm.2021.100262 |
0.467 |
|
| 2021 |
Ertl HCJ. T Cell-Mediated Immune Responses to AAV and AAV Vectors. Frontiers in Immunology. 12: 666666. PMID 33927727 DOI: 10.3389/fimmu.2021.666666 |
0.484 |
|
| 2021 |
Hasanpourghadi M, Novikov M, Ertl HCJ. COVID-19 Vaccines Based on Adenovirus Vectors. Trends in Biochemical Sciences. PMID 33810926 DOI: 10.1016/j.tibs.2021.03.002 |
0.438 |
|
| 2020 |
Rupprecht CE, Abela-Ridder B, Abila R, Amparo AC, Banyard A, Blanton J, Chanachai K, Dallmeier K, de Balogh K, Del Rio Vilas V, Ertl H, Freuling C, Hill R, Houillon G, Jakava-Viljanen M, et al. Towards rabies elimination in the Asia-Pacific region: From theory to practice. Biologicals : Journal of the International Association of Biological Standardization. PMID 32089431 DOI: 10.1016/J.Biologicals.2020.01.008 |
0.418 |
|
| 2020 |
Ertl H, Xiang Z, Li Y, Luber A, Magowan C, Zhou X. Glycoprotein D, a checkpoint inhibitor of early T-cell activation, to improve immunogenicity and efficacy of an HPV-16 vaccine in preclinical studies. Journal of Clinical Oncology. 38: 71-71. DOI: 10.1200/Jco.2020.38.5_Suppl.71 |
0.553 |
|
| 2019 |
Xiang Z, Kurupati RK, Li Y, Kuranda K, Zhou X, Mingozzi F, High KA, Ertl HCJ. The Effect of CpG Sequences on Capsid-Specific CD8 T Cell Responses to AAV Vector Gene Transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31839483 DOI: 10.1016/J.Ymthe.2019.11.014 |
0.438 |
|
| 2019 |
Ertl HCJ. New Rabies Vaccines for Use in Humans. Vaccines. 7. PMID 31226750 DOI: 10.3390/vaccines7020054 |
0.42 |
|
| 2019 |
Taylor E, Banyard AC, Bourhy H, Cliquet F, Ertl H, Fehlner-Gardiner C, Horton DL, Mani RS, Müller T, Rupprecht CE, Schnell MJ, Del Rio Vilas V, Fooks AR. Avoiding preventable deaths: The scourge of counterfeit rabies vaccines. Vaccine. PMID 30922698 DOI: 10.1016/J.Vaccine.2019.03.037 |
0.469 |
|
| 2019 |
Henry C, Zheng NY, Huang M, Cabanov A, Rojas KT, Kaur K, Andrews SF, Palm AE, Chen YQ, Li Y, Hoskova K, Utset HA, Vieira MC, Wrammert J, Ahmed R, ... ... Ertl HC, et al. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. Cell Host & Microbe. PMID 30795982 DOI: 10.1016/J.Chom.2019.01.002 |
0.707 |
|
| 2019 |
Ertl HCJ. Human immune responses to traditional and novel rabies vaccines. Revue Scientifique Et Technique (International Office of Epizootics). 37: 649-656. PMID 30747120 DOI: 10.20506/rst.37.2.2830 |
0.512 |
|
| 2018 |
Wang C, Dulal P, Zhou X, Xiang Z, Goharriz H, Banyard A, Green N, Brunner L, Ventura R, Collin N, Draper SJ, Hill AVS, Ashfield R, Fooks AR, Ertl HC, et al. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis. Plos Neglected Tropical Diseases. 12: e0006870. PMID 30372438 DOI: 10.1371/journal.pntd.0006870 |
0.395 |
|
| 2018 |
Agarwal D, Schmader KE, Kossenkov AV, Doyle S, Kurupati R, Ertl HCJ. Immune response to influenza vaccination in the elderly is altered by chronic medication use. Immunity & Ageing : I & A. 15: 19. PMID 30186359 DOI: 10.1186/s12979-018-0124-9 |
0.438 |
|
| 2018 |
Fooks AR, Banyard AC, Ertl HCJ. New human rabies vaccines in the pipeline. Vaccine. PMID 30153997 DOI: 10.1016/j.vaccine.2018.08.039 |
0.421 |
|
| 2018 |
Kurupati RK, Zhou X, Xiang Z, Keller LH, Ertl HCJ. Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma. Cancer Immunology, Immunotherapy : Cii. PMID 30051333 DOI: 10.1007/s00262-018-2201-5 |
0.518 |
|
| 2018 |
Tuyishime S, Haut LH, Kurupati RK, Billingsley JM, Carnathan D, Gangahara S, Styles TM, Xiang Z, Li Y, Zopfs M, Liu Q, Zhou X, Lewis MG, Amara RR, Bosinger S, ... ... Ertl HCJ, et al. Correlates of Protection Against SIV Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors. Ebiomedicine. PMID 29685793 DOI: 10.1016/J.Ebiom.2018.02.025 |
0.854 |
|
| 2018 |
Cobey S, Gouma S, Parkhouse K, Chambers BS, Ertl HC, Schmader KE, Halpin RA, Lin X, Stockwell TB, Das SR, Landon E, Tesic V, Youngster I, Pinsky BA, Wentworth DE, et al. Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29471464 DOI: 10.1093/Cid/Ciy097 |
0.667 |
|
| 2018 |
de Camargo TM, de Freitas EO, Gimenez AM, Lima LC, de Almeida Caramico K, Françoso KS, Bruna-Romero O, Andolina C, Nosten F, Rénia L, Ertl HCJ, Nussenzweig RS, Nussenzweig V, Rodrigues MM, Reyes-Sandoval A, et al. Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge. Scientific Reports. 8: 1118. PMID 29348479 DOI: 10.1038/S41598-017-19063-6 |
0.405 |
|
| 2017 |
Ertl HCJ. Preclinical models to assess the immunogenicity of AAV vectors. Cellular Immunology. PMID 29195742 DOI: 10.1016/j.cellimm.2017.11.006 |
0.461 |
|
| 2017 |
Kurupati RK, Kossenkoff A, Kannan S, Haut LH, Doyle S, Yin X, Schmader KE, Liu Q, Showe L, Ertl HCJ. The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged. Vaccine. PMID 28583307 DOI: 10.1016/J.Vaccine.2017.05.074 |
0.403 |
|
| 2017 |
Afkhami S, LeClair DA, Haddadi S, Lai R, Toniolo SP, Ertl HC, Cranston ED, Thompson MR, Xing Z. Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo. Vaccine. PMID 28438408 DOI: 10.1016/j.vaccine.2017.04.026 |
0.457 |
|
| 2017 |
Kessels JA, Recuenco S, Navarro-Vela AM, Deray R, Vigilato M, Ertl H, Durrheim D, Rees H, Nel LH, Abela-Ridder B, Briggs D. Pre-exposure rabies prophylaxis: a systematic review. Bulletin of the World Health Organization. 95: 210-219C. PMID 28250534 DOI: 10.2471/Blt.16.173039 |
0.354 |
|
| 2017 |
Ertl HC, High KA. The impact of AAV capsid-specific T cell responses on design and outcome of clinical gene transfer trials with recombinant AAV vectors - an evolving controversy. Human Gene Therapy. PMID 28042943 DOI: 10.1089/Hum.2016.172 |
0.385 |
|
| 2016 |
Dawany N, Parzych EM, Showe LC, Ertl HC. Age-related changes in the gene expression profile of antigen-specific mouse CD8+ T cells can be partially reversed by blockade of the BTLA/CD160 pathways during vaccination. Aging. PMID 27922818 DOI: 10.18632/aging.101105 |
0.422 |
|
| 2016 |
Kurupati R, Kossenkov A, Haut L, Kannan S, Xiang Z, Li Y, Doyle S, Liu Q, Schmader K, Showe L, Ertl H. Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood. Oncotarget. PMID 27588486 DOI: 10.18632/Oncotarget.11704 |
0.504 |
|
| 2016 |
Emmer KL, Wieczorek L, Tuyishime S, Molnar S, Polonis VR, Ertl HC. Antibody responses to prime-boost vaccination with an HIV-1 gp145 Env protein and chimpanzee adenovirus vectors expressing HIV-1 gp140. Aids (London, England). PMID 27525550 DOI: 10.1097/Qad.0000000000001224 |
0.812 |
|
| 2016 |
Ertl HC. Viral vectors as vaccine carriers. Current Opinion in Virology. 21: 1-8. PMID 27327517 DOI: 10.1016/j.coviro.2016.06.001 |
0.523 |
|
| 2016 |
Zhou X, Xiang Z, Ertl HC. Vaccine Design: Replication-Defective Adenovirus Vectors. Methods in Molecular Biology (Clifton, N.J.). 1404: 329-49. PMID 27076309 DOI: 10.1007/978-1-4939-3389-1_23 |
0.434 |
|
| 2016 |
Zhang Y, Ertl HC. Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors. Oncotarget. PMID 26943036 DOI: 10.18632/oncotarget.7818 |
0.344 |
|
| 2016 |
Rupprecht CE, Nagarajan T, Ertl H. Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention. Expert Review of Vaccines. 1-19. PMID 26796599 DOI: 10.1586/14760584.2016.1140040 |
0.45 |
|
| 2016 |
Ertl HCJ. Adenoviral Vector Vaccines Antigen Transgene Adenoviral Vectors For Gene Therapy: Second Edition. 551-570. DOI: 10.1016/B978-0-12-800276-6.00021-8 |
0.491 |
|
| 2015 |
Kannan S, Kossenkov A, Kurupati RK, Xiang JZ, Doyle SA, Schmader KE, Schowe L, Ertl HC. A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged. Aging. PMID 26637961 |
0.456 |
|
| 2015 |
Hui DJ, Edmonson SC, Podsakoff GM, Pien GC, Ivanciu L, Camire RM, Ertl H, Mingozzi F, High KA, Basner-Tschakarjan E. AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes. Molecular Therapy. Methods & Clinical Development. 2: 15029. PMID 26445723 DOI: 10.1038/Mtm.2015.29 |
0.529 |
|
| 2015 |
Kannan S, Kurupati RK, Doyle SA, Freeman GJ, Schmader KE, Ertl HC. BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine. Oncotarget. 6: 19445-55. PMID 26277622 DOI: 10.18632/oncotarget.4597 |
0.466 |
|
| 2015 |
Song Y, Wang X, Zhang H, Tang X, Li M, Yao J, Jin X, Ertl HC, Zhou D. Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation. Journal of Virology. 89: 7841-51. PMID 25995265 DOI: 10.1128/JVI.00976-15 |
0.41 |
|
| 2015 |
Jeyanathan M, Thanthrige-Don N, Afkhami S, Lai R, Damjanovic D, Zganiacz A, Feng X, Yao XD, Rosenthal KL, Fe Medina M, Gauldie J, Ertl HC, Xing Z. Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection. Mucosal Immunology. PMID 25872483 DOI: 10.1038/Mi.2015.29 |
0.383 |
|
| 2015 |
Zhang H, Tang X, Zhu C, Song Y, Yin J, Xu J, Ertl HC, Zhou D. Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge. Gene Therapy. PMID 25835311 DOI: 10.1038/gt.2015.31 |
0.319 |
|
| 2015 |
Rogers GL, Suzuki M, Zolotukhin I, Markusic DM, Morel LM, Lee B, Ertl HC, Herzog RW. Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer. Journal of Innate Immunity. 7: 302-14. PMID 25612611 DOI: 10.1159/000369273 |
0.367 |
|
| 2015 |
Carnathan DG, Wetzel KS, Yu J, Lee ST, Johnson BA, Paiardini M, Yan J, Morrow MP, Sardesai NY, Weiner DB, Ertl HC, Silvestri G. Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America. 112: 518-23. PMID 25550504 DOI: 10.1073/Pnas.1407466112 |
0.557 |
|
| 2014 |
Herati RS, Reuter MA, Dolfi DV, Mansfield KD, Aung H, Badwan OZ, Kurupati RK, Kannan S, Ertl H, Schmader KE, Betts MR, Canaday DH, Wherry EJ. Circulating CXCR5+PD-1+response predicts influenza vaccine antibody responses in young adults but not elderly adults Journal of Immunology. 193: 3528-3537. PMID 25172499 DOI: 10.4049/Jimmunol.1302503 |
0.537 |
|
| 2014 |
Small JC, Haut LH, Bian A, Ertl HC. The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses. Journal of Leukocyte Biology. 96: 821-31. PMID 25082150 DOI: 10.1189/Jlb.1A0813-451Rr |
0.7 |
|
| 2014 |
Zhang Y, Ertl HC. The effect of adjuvanting cancer vaccines with herpes simplex virus glycoprotein D on melanoma-driven CD8+ T cell exhaustion. Journal of Immunology (Baltimore, Md. : 1950). 193: 1836-46. PMID 25024391 DOI: 10.4049/jimmunol.1302029 |
0.564 |
|
| 2014 |
Tuyishime S, Haut LH, Zhu C, Ertl HC. Enhancement of recombinant adenovirus vaccine-induced primary but not secondary systemic and mucosal immune responses by all-trans retinoic acid. Vaccine. 32: 3386-92. PMID 24780251 DOI: 10.1016/J.Vaccine.2014.04.028 |
0.823 |
|
| 2014 |
Leskowitz R, Fogg MH, Zhou XY, Kaur A, Silveira EL, Villinger F, Lieberman PM, Wang F, Ertl HC. Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques. Journal of Virology. 88: 4721-35. PMID 24522914 DOI: 10.1128/Jvi.03744-13 |
0.851 |
|
| 2014 |
Xiang ZQ, Greenberg L, Ertl HC, Rupprecht CE. Protection of non-human primates against rabies with an adenovirus recombinant vaccine. Virology. 450: 243-9. PMID 24503087 DOI: 10.1016/j.virol.2013.12.029 |
0.471 |
|
| 2014 |
Teixeira LH, Tararam CA, Lasaro MO, Camacho AG, Ersching J, Leal MT, Herrera S, Bruna-Romero O, Soares IS, Nussenzweig RS, Ertl HC, Nussenzweig V, Rodrigues MM. Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents. Infection and Immunity. 82: 793-807. PMID 24478093 DOI: 10.1128/Iai.01410-13 |
0.432 |
|
| 2014 |
Sholukh AM, Byrareddy SN, Shanmuganathan V, Hemashettar G, Lakhashe SK, Rasmussen RA, Watkins JD, Vyas HK, Thorat S, Brandstoetter T, Mukhtar MM, Yoon JK, Novembre FJ, Villinger F, Landucci G, ... ... Ertl HC, et al. Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose. Retrovirology. 11: 8. PMID 24444350 DOI: 10.1186/1742-4690-11-8 |
0.375 |
|
| 2014 |
Small JC, Kurupati RK, Zhou X, Bian A, Chi E, Li Y, Xiang Z, Ertl HC. Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes. Human Gene Therapy. 25: 328-38. PMID 24367921 DOI: 10.1089/Hum.2013.216 |
0.606 |
|
| 2014 |
Wu TL, Li H, Faust SM, Chi E, Zhou S, Wright F, High KA, Ertl HC. CD8+ T cell recognition of epitopes within the capsid of adeno-associated virus 8-based gene transfer vectors depends on vectors' genome. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 42-51. PMID 24077034 DOI: 10.1038/Mt.2013.218 |
0.448 |
|
| 2014 |
Ertl HCJ. Adenoviral Vectors as Vaccine Carriers for Prevention of Rabies Current Laboratory Techniques in Rabies Diagnosis, Research and Prevention. 1: 265-274. DOI: 10.1016/B978-0-12-800014-4.00025-1 |
0.458 |
|
| 2013 |
Parzych EM, DiMenna LJ, Latimer BP, Small JC, Kannan S, Manson B, Lasaro MO, Wherry EJ, Ertl HC. Influenza virus specific CD8⁺ T cells exacerbate infection following high dose influenza challenge of aged mice. Biomed Research International. 2013: 876314. PMID 24187666 DOI: 10.1155/2013/876314 |
0.724 |
|
| 2013 |
Dolfi DV, Mansfield KD, Kurupati RK, Kannan S, Doyle SA, Ertl HC, Schmader KE, Wherry EJ. Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. Plos One. 8: e77164. PMID 24155927 DOI: 10.1371/Journal.Pone.0077164 |
0.566 |
|
| 2013 |
Silveira EL, Fogg MH, Leskowitz RM, Ertl HC, Wiseman RW, O'Connor DH, Lieberman P, Wang F, Villinger F. Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques. Journal of Virology. 87: 13904-10. PMID 24089556 DOI: 10.1128/Jvi.01947-13 |
0.847 |
|
| 2013 |
Cervasi B, Carnathan DG, Sheehan KM, Micci L, Paiardini M, Kurupati R, Tuyishime S, Zhou XY, Else JG, Ratcliffe SJ, Ertl HC, Silvestri G. Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac. Journal of Virology. 87: 9420-30. PMID 23804645 DOI: 10.1128/Jvi.01456-13 |
0.855 |
|
| 2013 |
Leskowitz RM, Zhou XY, Villinger F, Fogg MH, Kaur A, Lieberman PM, Wang F, Ertl HC. CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques. Journal of Virology. 87: 8351-62. PMID 23698300 DOI: 10.1128/Jvi.00852-13 |
0.83 |
|
| 2013 |
Kurupati RK, Kannan S, Xiang ZQ, Doyle S, Ratcliffe S, Schmader KE, Ertl HC. B cell responses to the 2011/12-influenza vaccine in the aged. Aging. 5: 209-26. PMID 23674565 |
0.474 |
|
| 2013 |
Parzych EM, Li H, Yin X, Liu Q, Wu TL, Podsakoff GM, High KA, Levine MH, Ertl HC. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Human Gene Therapy. 24: 431-42. PMID 23461589 DOI: 10.1089/Hum.2012.246 |
0.37 |
|
| 2013 |
Martino AT, Basner-Tschakarjan E, Markusic DM, Finn JD, Hinderer C, Zhou S, Ostrov DA, Srivastava A, Ertl HC, Terhorst C, High KA, Mingozzi F, Herzog RW. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. Blood. 121: 2224-33. PMID 23325831 DOI: 10.1182/Blood-2012-10-460733 |
0.391 |
|
| 2013 |
Kurupati R, Tuyishime S, Kossenkov AV, Sazanovich M, Haut LH, Lasaro MO, Ratcliffe SJ, Bosinger SE, Carnathan DG, Lewis M, Showe LC, Silvestri G, Ertl HC. Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques. Journal of Leukocyte Biology. 93: 437-48. PMID 23271702 DOI: 10.1189/Jlb.0612287 |
0.834 |
|
| 2013 |
Zhou D, Wu TL, Emmer KL, Kurupati R, Tuyishime S, Li Y, Giles-Davis W, Zhou X, Xiang Z, Liu Q, Ratcliffe SJ, Ertl HC. Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 696-706. PMID 23229092 DOI: 10.1038/Mt.2012.248 |
0.832 |
|
| 2013 |
Xiang ZQ, Ertl HCJ. Next Generation of Rabies Vaccines Rabies. 527-541. DOI: 10.1016/B978-0-12-396547-9.00014-6 |
0.45 |
|
| 2012 |
Hoffman BE, Ertl HC, Terhorst C, High KA, Herzog RW. Gene therapy research at the frontiers of viral immunology. Frontiers in Microbiology. 3: 182. PMID 22783235 DOI: 10.3389/Fmicb.2012.00182 |
0.357 |
|
| 2012 |
Liu Q, Ertl HC. Preventative childhood vaccination to rabies. Expert Opinion On Biological Therapy. 12: 1067-75. PMID 22724389 DOI: 10.1517/14712598.2012.691162 |
0.416 |
|
| 2012 |
Azzoni L, Foulkes AS, Firnhaber C, Yin X, Xiang ZQ, Li Y, Stevens W, Gross R, Ertl HC, Sanne I, Montaner LJ. Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals. Aids (London, England). 26: 1355-62. PMID 22516873 DOI: 10.1097/Qad.0B013E328354648E |
0.335 |
|
| 2012 |
Ertl HC. Progress in the development of hepatitis C virus vaccines. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 697-8. PMID 22472980 DOI: 10.1038/mt.2012.30 |
0.384 |
|
| 2012 |
Decman V, Laidlaw BJ, Doering TA, Leng J, Ertl HC, Goldstein DR, Wherry EJ. Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors. Journal of Immunology (Baltimore, Md. : 1950). 188: 1933-41. PMID 22246631 DOI: 10.4049/Jimmunol.1101098 |
0.33 |
|
| 2012 |
Wu T, Töpfer K, Lin SW, Li H, Bian A, Zhou XY, High KA, Ertl HC. Self-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genome. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 572-9. PMID 22186792 DOI: 10.1038/Mt.2011.280 |
0.726 |
|
| 2012 |
Ertl HC, Pasquini S, He Z, Deng H, Showe L, Giles-Davis W, Wang Y, O I, Marston H, Blaszczyk-Thurin M, Xiang Z. Genetic adjuvants. Methods in Molecular Medicine. 29: 251-60. PMID 21374325 DOI: 10.1385/1-59259-688-6:251 |
0.436 |
|
| 2011 |
Small JC, Ertl HC. Viruses - from pathogens to vaccine carriers. Current Opinion in Virology. 1: 241-5. PMID 22003377 DOI: 10.1016/J.Coviro.2011.07.009 |
0.69 |
|
| 2011 |
Li H, Ertl HC. Can Viruses be Modified to Achieve Sustained Gene Transfer. Frontiers in Microbiology. 2: 152. PMID 21808636 DOI: 10.3389/fmicb.2011.00152 |
0.32 |
|
| 2011 |
Lasaro MO, Sazanovich M, Giles-Davis W, Mrass P, Bunte RM, Sewell DA, Hussain SF, Fu YX, Weninger W, Paterson Y, Ertl HC. Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1727-36. PMID 21587210 DOI: 10.1038/Mt.2011.88 |
0.477 |
|
| 2011 |
Li H, Lasaro MO, Jia B, Lin SW, Haut LH, High KA, Ertl HC. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 2021-30. PMID 21587208 DOI: 10.1038/Mt.2011.81 |
0.421 |
|
| 2011 |
Ertl HC. The ideal vaccine: until death do us part. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 820-2. PMID 21532607 DOI: 10.1038/mt.2011.60 |
0.368 |
|
| 2011 |
Martino AT, Suzuki M, Markusic DM, Zolotukhin I, Ryals RC, Moghimi B, Ertl HC, Muruve DA, Lee B, Herzog RW. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver. Blood. 117: 6459-68. PMID 21474674 DOI: 10.1182/Blood-2010-10-314518 |
0.339 |
|
| 2011 |
Haut LH, Ratcliffe S, Pinto AR, Ertl H. Effect of preexisting immunity to adenovirus on transgene product-specific genital T cell responses on vaccination of mice with a homologous vector. The Journal of Infectious Diseases. 203: 1073-81. PMID 21450997 DOI: 10.1093/Infdis/Jiq161 |
0.682 |
|
| 2011 |
Li H, Tuyishime S, Wu TL, Giles-Davis W, Zhou D, Xiao W, High KA, Ertl HC. Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 536-46. PMID 21157435 DOI: 10.1038/Mt.2010.267 |
0.813 |
|
| 2011 |
Lasaro MO, Haut LH, Zhou X, Xiang Z, Zhou D, Li Y, Giles-Davis W, Li H, Engram JC, Dimenna LJ, Bian A, Sazanovich M, Parzych EM, Kurupati R, Small JC, ... ... Ertl HC, et al. Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 417-26. PMID 21081905 DOI: 10.1038/Mt.2010.238 |
0.847 |
|
| 2010 |
Hutnick NA, Carnathan DG, Dubey SA, Cox KS, Kierstead L, Makadonas G, Ratcliffe SJ, Lasaro MO, Robertson MN, Casimiro DR, Ertl HC, Betts MR. Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality. Plos One. 5: e14385. PMID 21203546 DOI: 10.1371/Journal.Pone.0014385 |
0.473 |
|
| 2010 |
Haut LH, Lin SW, Tatsis N, DiMenna LJ, Giles-Davis W, Pinto AR, Ertl HC. Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gag. European Journal of Immunology. 40: 3426-38. PMID 21108465 DOI: 10.1002/eji.201040440 |
0.551 |
|
| 2010 |
Zhou D, Zhou X, Bian A, Li H, Chen H, Small JC, Li Y, Giles-Davis W, Xiang Z, Ertl HC. An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector. Nature Protocols. 5: 1775-85. PMID 21030953 DOI: 10.1038/Nprot.2010.134 |
0.672 |
|
| 2010 |
Zhou D, Wu TL, Lasaro MO, Latimer BP, Parzych EM, Bian A, Li Y, Li H, Erikson J, Xiang Z, Ertl HC. A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 2182-9. PMID 20877342 DOI: 10.1038/Mt.2010.202 |
0.535 |
|
| 2010 |
Ersching J, Hernandez MI, Cezarotto FS, Ferreira JD, Martins AB, Switzer WM, Xiang Z, Ertl HC, Zanetti CR, Pinto AR. Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys. Virology. 407: 1-6. PMID 20797754 DOI: 10.1016/j.virol.2010.07.043 |
0.337 |
|
| 2010 |
Diniz MO, Lasaro MO, Ertl HC, Ferreira LC. Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D. Clinical and Vaccine Immunology : Cvi. 17: 1576-83. PMID 20739505 DOI: 10.1128/CVI.00264-10 |
0.527 |
|
| 2010 |
Chen H, Xiang ZQ, Li Y, Kurupati RK, Jia B, Bian A, Zhou DM, Hutnick N, Yuan S, Gray C, Serwanga J, Auma B, Kaleebu P, Zhou X, Betts MR, ... Ertl HC, et al. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae. Journal of Virology. 84: 10522-32. PMID 20686035 DOI: 10.1128/Jvi.00450-10 |
0.44 |
|
| 2010 |
Ertl HC, Lanzavecchia A. Current Opinion in Immunology. Vaccines. Introduction. Current Opinion in Immunology. 22: 355-7. PMID 20510596 DOI: 10.1016/j.coi.2010.05.001 |
0.433 |
|
| 2010 |
Lasaro MO, Ertl HC. Targeting inhibitory pathways in cancer immunotherapy. Current Opinion in Immunology. 22: 385-90. PMID 20466529 DOI: 10.1016/j.coi.2010.04.005 |
0.437 |
|
| 2010 |
Lanza SR, Menin A, Ertl HC, Báfica A, Pinto AR. Simian recombinant adenovirus delivered by the mucosal route modulates gammadelta T cells from murine genital tract. Vaccine. 28: 4600-8. PMID 20460181 DOI: 10.1016/J.Vaccine.2010.04.080 |
0.415 |
|
| 2010 |
DiMenna L, Latimer B, Parzych E, Haut LH, Töpfer K, Abdulla S, Yu H, Manson B, Giles-Davis W, Zhou D, Lasaro MO, Ertl HC. Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway. Journal of Immunology (Baltimore, Md. : 1950). 184: 5475-84. PMID 20410485 DOI: 10.4049/jimmunol.0903808 |
0.574 |
|
| 2010 |
Decman V, Laidlaw BJ, Dimenna LJ, Abdulla S, Mozdzanowska K, Erikson J, Ertl HC, Wherry EJ. Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection. Journal of Immunology (Baltimore, Md. : 1950). 184: 5151-9. PMID 20368274 DOI: 10.4049/Jimmunol.0902063 |
0.353 |
|
| 2010 |
Hutnick NA, Carnathan D, Demers K, Makedonas G, Ertl HC, Betts MR. Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive. Vaccine. 28: 1932-41. PMID 20188249 DOI: 10.1016/J.Vaccine.2009.10.091 |
0.407 |
|
| 2009 |
Müller T, Dietzschold B, Ertl H, Fooks AR, Freuling C, Fehlner-Gardiner C, Kliemt J, Meslin FX, Franka R, Rupprecht CE, Tordo N, Wanderler AI, Kieny MP. Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. Plos Neglected Tropical Diseases. 3: e542. PMID 19888334 DOI: 10.1371/Journal.Pntd.0000542 |
0.388 |
|
| 2009 |
Ertl HC. Novel vaccines to human rabies. Plos Neglected Tropical Diseases. 3: e515. PMID 19787033 DOI: 10.1371/journal.pntd.0000515 |
0.433 |
|
| 2009 |
DiMenna LJ, Ertl HC. Pandemic influenza vaccines. Current Topics in Microbiology and Immunology. 333: 291-321. PMID 19768412 DOI: 10.1007/978-3-540-92165-3_15 |
0.452 |
|
| 2009 |
Santra S, Sun Y, Korioth-Schmitz B, Fitzgerald J, Charbonneau C, Santos G, Seaman MS, Ratcliffe SJ, Montefiori DC, Nabel GJ, Ertl HCJ, Letvin NL. Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors Vaccine. 27: 5837-5845. PMID 19660588 DOI: 10.1016/J.Vaccine.2009.07.050 |
0.698 |
|
| 2009 |
Hutnick NA, Carnathan DG, Dubey SA, Makedonas G, Cox KS, Kierstead L, Ratcliffe SJ, Robertson MN, Casimiro DR, Ertl HC, Betts MR. Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells. Nature Medicine. 15: 876-8. PMID 19620962 DOI: 10.1038/Nm.1989 |
0.369 |
|
| 2009 |
Haut LH, Ertl HC. Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine. Journal of Leukocyte Biology. 86: 779-93. PMID 19597003 DOI: 10.1189/jlb.0209094 |
0.449 |
|
| 2009 |
Lasaro MO, Ertl HC. New insights on adenovirus as vaccine vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1333-9. PMID 19513019 DOI: 10.1038/mt.2009.130 |
0.502 |
|
| 2009 |
Tatsis N, Lasaro MO, Lin SW, Haut LH, Xiang ZQ, Zhou D, Dimenna L, Li H, Bian A, Abdulla S, Li Y, Giles-Davis W, Engram J, Ratcliffe SJ, Silvestri G, ... Ertl HC, et al. Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens. Journal of Immunology (Baltimore, Md. : 1950). 182: 6587-99. PMID 19414814 DOI: 10.4049/Jimmunol.0900317 |
0.52 |
|
| 2009 |
Li H, Lin SW, Giles-Davis W, Li Y, Zhou D, Xiang ZQ, High KA, Ertl HC. A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1215-24. PMID 19367258 DOI: 10.1038/Mt.2009.79 |
0.37 |
|
| 2009 |
Pichla-Gollon SL, Lin SW, Hensley SE, Lasaro MO, Herkenhoff-Haut L, Drinker M, Tatsis N, Gao GP, Wilson JM, Ertl HC, Bergelson JM. Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo. Journal of Virology. 83: 5567-73. PMID 19279092 DOI: 10.1128/Jvi.00405-09 |
0.699 |
|
| 2009 |
Wu TL, Ertl HC. Immune barriers to successful gene therapy. Trends in Molecular Medicine. 15: 32-9. PMID 19101205 DOI: 10.1016/J.Molmed.2008.11.005 |
0.336 |
|
| 2009 |
Lasaro MO, Ertl HC. Potentiating vaccine immunogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system. Human Vaccines. 5: 6-14. PMID 18927514 DOI: 10.4161/hv.5.1.6399 |
0.345 |
|
| 2009 |
Tatsis N, Lasaro MO, Lin SW, Haut LH, Xiang ZQ, Zhou D, DiMenna L, Li H, Bian A, Abdulla S, Li Y, Giles-Davis W, Engram J, Ratcliffe SJ, Silvestri G, ... Ertl HC, et al. Adenovirus vector-induced immune responses in nonhuman primates: Responses to prime boost regimens (Journal of Immunology (2009) 182, (6587-6599)) Journal of Immunology. 183: 7611. DOI: 10.4049/jimmunol.0990099 |
0.342 |
|
| 2009 |
Hutnick N, Carnathan D, Dubey S, Cox K, Ratcliffe S, Robertson MN, Casimiro DR, Ertl HC, Betts MR. P16-09. Adenovirus 5 vector HIV vaccination does not affect mucosal homing markers on Ad5-specific CD4+ T-cells in humans Retrovirology. 6: P238. DOI: 10.1186/1742-4690-6-S3-P238 |
0.492 |
|
| 2008 |
Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, Gilbert SC, Gao G, Ertl HC, Wilson JC, Hill AV. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei. European Journal of Immunology. 38: 732-41. PMID 18266272 DOI: 10.1002/Eji.200737672 |
0.565 |
|
| 2008 |
Lasaro MO, Tatsis N, Hensley SE, Whitbeck JC, Lin SW, Rux JJ, Wherry EJ, Cohen GH, Eisenberg RJ, Ertl HC. Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses. Nature Medicine. 14: 205-12. PMID 18193057 DOI: 10.1038/Nm1704 |
0.682 |
|
| 2008 |
Iparraguirre A, Tobias JW, Hensley SE, Masek KS, Cavanagh LL, Rendl M, Hunter CA, Ertl HC, von Andrian UH, Weninger W. Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide. Journal of Leukocyte Biology. 83: 610-20. PMID 18029397 DOI: 10.1189/Jlb.0807511 |
0.622 |
|
| 2008 |
Lin SW, Ertl HCJ. Safety of adeno-associated viral vectors Future Virology. 3: 491-503. DOI: 10.2217/17460794.3.5.491 |
0.459 |
|
| 2007 |
Lin SW, Hensley SE, Tatsis N, Lasaro MO, Ertl HC. Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice. The Journal of Clinical Investigation. 117: 3958-70. PMID 18008010 DOI: 10.1172/Jci33138 |
0.752 |
|
| 2007 |
Tatsis N, Lin SW, Harris-McCoy K, Garber DA, Feinberg MB, Ertl HC. Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing. Virology. 367: 156-67. PMID 17590405 DOI: 10.1016/J.Virol.2007.05.028 |
0.518 |
|
| 2007 |
Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou D, Lin SW, Bian A, Xiang ZQ, Iparraguirre A, Lopez-Camacho C, Wherry EJ, Ertl HC. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood. 110: 1916-23. PMID 17510320 DOI: 10.1182/Blood-2007-02-062117 |
0.767 |
|
| 2007 |
McCoy K, Tatsis N, Korioth-Schmitz B, Lasaro MO, Hensley SE, Lin SW, Li Y, Giles-Davis W, Cun A, Zhou D, Xiang Z, Letvin NL, Ertl HC. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors. Journal of Virology. 81: 6594-604. PMID 17428852 DOI: 10.1128/Jvi.02497-06 |
0.762 |
|
| 2007 |
Mingozzi F, Maus MV, Hui DJ, Sabatino DE, Murphy SL, Rasko JE, Ragni MV, Manno CS, Sommer J, Jiang H, Pierce GF, Ertl HC, High KA. CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nature Medicine. 13: 419-22. PMID 17369837 DOI: 10.1038/Nm1549 |
0.459 |
|
| 2007 |
Li H, Murphy SL, Giles-Davis W, Edmonson S, Xiang Z, Li Y, Lasaro MO, High KA, Ertl HC. Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 792-800. PMID 17245353 DOI: 10.1038/Sj.Mt.6300090 |
0.41 |
|
| 2007 |
Hensley SE, Cun AS, Giles-Davis W, Li Y, Xiang Z, Lasaro MO, Williams BR, Silverman RH, Ertl HC. Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 393-403. PMID 17235319 DOI: 10.1038/Sj.Mt.6300024 |
0.636 |
|
| 2007 |
Lin SW, Cun AS, Harris-McCoy K, Ertl HC. Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut. Vaccine. 25: 2187-93. PMID 17229501 DOI: 10.1016/j.vaccine.2006.11.044 |
0.504 |
|
| 2007 |
Tatsis N, Blejer A, Lasaro MO, Hensley SE, Cun A, Tesema L, Li Y, Gao GP, Xiang ZQ, Zhou D, Wilson JM, Ertl HC. A CD46-binding chimpanzee adenovirus vector as a vaccine carrier. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 608-17. PMID 17228314 DOI: 10.1038/Sj.Mt.6300078 |
0.729 |
|
| 2007 |
de Souza AP, Haut LH, Silva R, Ferreira SI, Zanetti CR, Ertl HC, Pinto AR. Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus. Vaccine. 25: 109-16. PMID 16914235 DOI: 10.1016/j.vaccine.2006.07.011 |
0.47 |
|
| 2006 |
Zhou D, Cun A, Li Y, Xiang Z, Ertl HC. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 662-72. PMID 16797238 DOI: 10.1016/j.ymthe.2006.03.027 |
0.465 |
|
| 2006 |
Vanniasinkam T, Ertl H, Tang Q. Trichostatin-A enhances adaptive immune responses to DNA vaccination. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 36: 292-7. PMID 16765083 DOI: 10.1016/J.Jcv.2006.04.009 |
0.456 |
|
| 2006 |
Zhou D, Ertl HC. Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections. Expert Opinion On Biological Therapy. 6: 63-72. PMID 16370915 DOI: 10.1517/14712598.6.1.63 |
0.489 |
|
| 2006 |
Tatsis N, Tesema L, Robinson ER, Giles-Davis W, McCoy K, Gao GP, Wilson JM, Ertl HC. Chimpanzee-origin adenovirus vectors as vaccine carriers. Gene Therapy. 13: 421-9. PMID 16319951 DOI: 10.1038/Sj.Gt.3302675 |
0.468 |
|
| 2006 |
Vanniasinkam T, Reddy ST, Ertl HCJ. DNA immunization using a non-viral promoter Virology. 344: 412-420. PMID 16226783 DOI: 10.1016/J.Virol.2005.08.040 |
0.496 |
|
| 2006 |
Mingozzi F, Maus MV, Sabatino DE, Hui DJ, Rasko JE, Ragni MV, Manno CS, Ertl HC, High KA. AAV-2 Capsid-Specific CD8+ T Cells Limit the Duration of Gene Therapy in Humans and Cross-React with AAV-8 Capsid. Blood. 108: 455-455. DOI: 10.1182/Blood.V108.11.455.455 |
0.442 |
|
| 2005 |
Sabatino DE, Mingozzi F, Hui DJ, Chen H, Colosi P, Ertl HC, High KA. Identification of mouse AAV capsid-specific CD8+ T cell epitopes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 1023-33. PMID 16263332 DOI: 10.1016/J.Ymthe.2005.09.009 |
0.391 |
|
| 2005 |
Hensley SE, Giles-Davis W, McCoy KC, Weninger W, Ertl HC. Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors. Journal of Immunology (Baltimore, Md. : 1950). 175: 6032-41. PMID 16237098 DOI: 10.4049/Jimmunol.175.9.6032 |
0.688 |
|
| 2005 |
Lasaro MO, Diniz MO, Reyes-Sandoval A, Ertl HC, Ferreira LC. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1. Microbes and Infection / Institut Pasteur. 7: 1541-50. PMID 16213178 DOI: 10.1016/j.micinf.2005.05.024 |
0.451 |
|
| 2005 |
Ertl HC. Challenges of immune responses in gene replacement therapy. Idrugs : the Investigational Drugs Journal. 8: 736-8. PMID 16118696 |
0.349 |
|
| 2005 |
Ertl HC. Immunological insights from genetic vaccines. Virus Research. 111: 89-92. PMID 15896407 DOI: 10.1016/j.virusres.2005.03.015 |
0.499 |
|
| 2005 |
Vanniasinkam T, Ertl HCJ. Adenoviral gene delivery for HIV-1 vaccination Current Gene Therapy. 5: 203-212. PMID 15853728 DOI: 10.2174/1566523053544236 |
0.574 |
|
| 2005 |
Xiang ZQ, Gao GP, Reyes-Sandoval A, Li Y, Wilson JM, Ertl HCJ. Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier Journal of Virology. 79: 3888-3888. DOI: 10.1128/JVI.79.6.3888.2005 |
0.461 |
|
| 2004 |
Tatsis N, Ertl HC. Adenoviruses as vaccine vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 616-29. PMID 15451446 DOI: 10.1016/j.ymthe.2004.07.013 |
0.508 |
|
| 2004 |
Reyes-Sandoval A, Fitzgerald JC, Grant R, Roy S, Xiang ZQ, Li Y, Gao GP, Wilson JM, Ertl HC. Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes. Journal of Virology. 78: 7392-9. PMID 15220412 DOI: 10.1128/Jvi.78.14.7392-7399.2004 |
0.755 |
|
| 2004 |
Wlazlo AP, Deng H, Giles-Davis W, Ertl HC. DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins. Cancer Gene Therapy. 11: 457-64. PMID 15118761 DOI: 10.1038/sj.cgt.7700723 |
0.441 |
|
| 2004 |
Reyes-Sandoval A, Ertl HCJ. CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses Molecular Therapy. 9: 249-261. PMID 14759809 DOI: 10.1016/j.ymthe.2003.11.008 |
0.369 |
|
| 2004 |
Pinto AR, Fitzgerald JC, Gao GP, Wilson JM, Ertl HC. Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector. Vaccine. 22: 697-703. PMID 14741162 DOI: 10.1016/J.Vaccine.2003.08.029 |
0.701 |
|
| 2004 |
Sabatino DE, Mingozzi F, Chen H, Colosi P, Ertl HC, High KA. Identification of the AAV2 Capsid CD8+ T Cell Epitope in C57BL/6 Mice. Blood. 104: 3188-3188. DOI: 10.1182/Blood.V104.11.3188.3188 |
0.357 |
|
| 2003 |
Kowalczyk DW, Wlazlo AP, Giles-Davis W, Kammer AR, Mukhopadhyay S, Ertl HC. Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attack. Cancer Gene Therapy. 10: 870-8. PMID 14712313 DOI: 10.1038/sj.cgt.7700653 |
0.403 |
|
| 2003 |
Pinto AR, Fitzgerald JC, Giles-Davis W, Gao GP, Wilson JM, Ertl HC. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers. Journal of Immunology (Baltimore, Md. : 1950). 171: 6774-9. PMID 14662882 DOI: 10.4049/Jimmunol.171.12.6774 |
0.758 |
|
| 2003 |
Xiang Z, Li Y, Gao G, Wilson JM, Ertl HC. Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice. Journal of Immunology (Baltimore, Md. : 1950). 171: 4287-93. PMID 14530353 DOI: 10.4049/Jimmunol.171.8.4287 |
0.503 |
|
| 2003 |
Xiang ZQ, Gao GP, Reyes-Sandoval A, Li Y, Wilson JM, Ertl HC. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier. Journal of Virology. 77: 10780-9. PMID 14512528 DOI: 10.1128/Jvi.77.20.10780-10789.2003 |
0.505 |
|
| 2003 |
O I, Blaszczyk-Thurin M, Shen CT, Ertl HC. A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma. Cancer Gene Therapy. 10: 678-88. PMID 12944987 DOI: 10.1038/sj.cgt.7700620 |
0.56 |
|
| 2003 |
Ertl HC. Rabies DNA vaccines for protection and therapeutic treatment. Expert Opinion On Biological Therapy. 3: 639-44. PMID 12831368 DOI: 10.1517/14712598.3.4.639 |
0.414 |
|
| 2003 |
Xiang ZQ, Gao GP, Li Y, Wilson JM, Ertl HC. T helper cell-independent antibody responses to the transgene product of an e1-deleted adenoviral vaccine require NK1.1 T cells. Virology. 305: 397-405. PMID 12573585 DOI: 10.1006/Viro.2002.1700 |
0.572 |
|
| 2003 |
Fitzgerald JC, Gao GP, Reyes-Sandoval A, Pavlakis GN, Xiang ZQ, Wlazlo AP, Giles-Davis W, Wilson JM, Ertl HC. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. Journal of Immunology (Baltimore, Md. : 1950). 170: 1416-22. PMID 12538702 DOI: 10.4049/Jimmunol.170.3.1416 |
0.748 |
|
| 2003 |
Vinner L, Wee EG, Patel S, Corbet S, Gao GP, Nielsen C, Wilson JM, Ertl HC, Hanke T, Fomsgaard A. Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost. The Journal of General Virology. 84: 203-13. PMID 12533717 DOI: 10.1099/Vir.0.18589-0 |
0.46 |
|
| 2003 |
Pinto AR, Reyes-Sandoval A, Ertl HCJ. Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus Cellular Immunology. 224: 105-112. DOI: 10.1016/j.cellimm.2003.08.006 |
0.518 |
|
| 2002 |
Ertl HC. Technology evaluation: ALVAC-CEA/B7.1, Aventis Pasteur/Therion. Current Opinion in Molecular Therapeutics. 4: 601-5. PMID 12596363 |
0.333 |
|
| 2002 |
Blaszczyk-Thurin M, O I, Ertl HCJ. An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53 Scandinavian Journal of Immunology. 56: 361-375. PMID 12234257 DOI: 10.1046/j.1365-3083.2002.01119.x |
0.522 |
|
| 2002 |
Deng H, Kowalczyk D, O I, Blaszczyk-Thurin M, Quan Xiang Z, Giles-Davis W, Ertl HC. A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line. Cellular Immunology. 215: 20-31. PMID 12142033 |
0.464 |
|
| 2002 |
Kammer AR, Ertl HC. Rabies vaccines: from the past to the 21st century. Hybridoma and Hybridomics. 21: 123-7. PMID 12031102 DOI: 10.1089/153685902317401726 |
0.437 |
|
| 2002 |
Insug O, Ku G, Ertl HC, Blaszczyk-Thurin M. A dendritic cell vaccine induces protective immunity to intracranial growth of glioma. Anticancer Research. 22: 613-21. PMID 12014629 |
0.511 |
|
| 2002 |
Reyes-Sandoval A, Ertl HC. DNA vaccines. Current Molecular Medicine. 1: 217-43. PMID 11899073 DOI: 10.2174/1566524013363898 |
0.478 |
|
| 2002 |
Xiang Z, Gao G, Reyes-Sandoval A, Cohen CJ, Li Y, Bergelson JM, Wilson JM, Ertl HC. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. Journal of Virology. 76: 2667-75. PMID 11861833 DOI: 10.1128/Jvi.76.6.2667-2675.2002 |
0.522 |
|
| 2002 |
Lees CY, Briggs DJ, Wu X, Davis RD, Moore SM, Gordon C, Xiang Z, Ertl HC, Tang DC, Fu ZF. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein. Veterinary Microbiology. 85: 295-303. PMID 11856579 DOI: 10.1016/S0378-1135(01)00523-5 |
0.399 |
|
| 2001 |
Kowalczyk DW, Wlazlo AP, Blaszczyk-Thurin M, Xiang ZQ, Giles-Davis W, Ertl HC. A method that allows easy characterization of tumor-infiltrating lymphocytes. Journal of Immunological Methods. 253: 163-75. PMID 11384678 DOI: 10.1016/S0022-1759(01)00356-8 |
0.408 |
|
| 2001 |
Kowalczyk DW, Wlazlo AP, Shane S, Ertl HCJ. Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16 Vaccine. 19: 3583-3590. PMID 11348726 DOI: 10.1016/S0264-410X(01)00070-6 |
0.355 |
|
| 2001 |
Wlazlo AP, Ertl HCJ. DNA tumor vaccines Archivum Immunologiae Et Therapiae Experimentalis. 49: 1-11. PMID 11266084 |
0.516 |
|
| 2000 |
Fields PA, Kowalczyk DW, Arruda VR, Armstrong E, McCleland ML, Hagstrom JN, Pasi KJ, Ertl HCJ, Herzog RW, High KA. Role of Vector in Activation of T Cell Subsets in Immune Responses against the Secreted Transgene Product Factor IX Molecular Therapy. 1: 225-235. PMID 10933938 DOI: 10.1006/Mthe.2000.0032 |
0.386 |
|
| 2000 |
Kowalczyk DW, Wlazlo AP, Giles-Davis W, Ertl HC. Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8(+) T cells. Journal of Immunological Methods. 241: 131-9. PMID 10915855 DOI: 10.1016/S0022-1759(00)00208-8 |
0.367 |
|
| 2000 |
Tims T, Briggs DJ, Davis RD, Moore SM, Xiang Z, Ertl HC, Fu ZF. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies. Vaccine. 18: 2804-7. PMID 10812222 DOI: 10.1016/S0264-410X(00)00088-8 |
0.507 |
|
| 2000 |
He Z, Wlazlo AP, Kowalczyk DW, Cheng J, Xiang ZQ, Giles-Davis W, Ertl HC. Viral recombinant vaccines to the E6 and E7 antigens of HPV-16. Virology. 270: 146-61. PMID 10772987 DOI: 10.1006/viro.2000.0271 |
0.401 |
|
| 2000 |
Pasquini S, Deng H, Reddy ST, Giles-Davis W, Ertl HC. The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector. Gene Therapy. 6: 1448-55. PMID 10467369 DOI: 10.1038/sj.gt.3300964 |
0.406 |
|
| 1999 |
Reddy ST, Ertl HCJ. The potential use of DNA vaccines for neonatal immunization Current Opinion in Molecular Therapeutics. 1: 22-29. PMID 11249679 |
0.39 |
|
| 1999 |
Kowalczyk DW, Ertl HCJ. Immune responses to DNA vaccines Cellular and Molecular Life Sciences. 55: 751-770. PMID 10379361 DOI: 10.1007/s000180050330 |
0.516 |
|
| 1999 |
Xiang ZQ, Pasquini S, Ertl HCJ. Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant Journal of Immunology. 162: 6716-6723. PMID 10352290 |
0.489 |
|
| 1999 |
Xiang Z, Ertl HCJ. Induction of mucosal immunity with a replication-defective adenoviral recombinant Vaccine. 17: 2003-2008. PMID 10217600 DOI: 10.1016/S0264-410X(98)00449-6 |
0.358 |
|
| 1998 |
Wang Y, Xiang Z, Pasquini S, Ertl HCJ. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus Journal of Virology. 72: 1790-1796. PMID 9499029 |
0.529 |
|
| 1998 |
Xiang ZQ, Pasquini S, He Z, Deng H, Wang Y, Blaszczyk-Thurin MA, Ertl HC. Genetic vaccines--a revolution in vaccinology? Springer Seminars in Immunopathology. 19: 257-68. PMID 9406351 DOI: 10.1007/BF00870273 |
0.349 |
|
| 1997 |
Pasquini S, Xiang Z, Wang Y, He Z, Deng H, Blaszczyk-Thurin M, Ertl HC. Cytokines and costimulatory molecules as genetic adjuvants. Immunology and Cell Biology. 75: 397-401. PMID 9315484 DOI: 10.1038/icb.1997.62 |
0.355 |
|
| 1997 |
Xiang ZQ, He Z, Wang Y, Ertl HCJ. The effect of interferon-γ on genetic immunization Vaccine. 15: 896-898. PMID 9234542 DOI: 10.1016/S0264-410X(96)00269-1 |
0.428 |
|
| 1997 |
Wang Y, Xiang Z, Pasquini S, Ertl HCJ. Immune response to neonatal genetic immunization Virology. 228: 278-284. PMID 9123835 DOI: 10.1006/viro.1996.8384 |
0.487 |
|
| 1997 |
Wang Y, Xiang Z, Pasquini S, Ertl HCJ. The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus Journal of Virology. 71: 3677-3683. PMID 9094641 |
0.509 |
|
| 1996 |
Ertl HCJ, Xiang ZQ. Genetic immunization Viral Immunology. 9: 1-9. PMID 8733914 |
0.443 |
|
| 1996 |
Xiang ZQ, Yang Y, Wilson JM, Ertl HCJ. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier Virology. 219: 220-227. PMID 8623532 DOI: 10.1006/Viro.1996.0239 |
0.519 |
|
| 1996 |
Ertl HCJ, Xiang Z. Novel vaccine approaches Journal of Immunology. 156: 3579-3582. PMID 8621889 |
0.495 |
|
| 1995 |
Xiang ZQ, Knowles BB, McCarrick JW, Ertl HCJ. Immune effector mechanisms required for protection to rabies virus Virology. 214: 398-404. PMID 8553540 DOI: 10.1006/Viro.1995.0049 |
0.428 |
|
| 1995 |
Ertl HCJ, Verma P, He Z, Xiang ZQ. Plasmid vectors as anti-viral vaccines Annals of the New York Academy of Sciences. 772: 77-87. PMID 8546415 DOI: 10.1111/j.1749-6632.1995.tb44733.x |
0.471 |
|
| 1995 |
Xiang Z, Ertl HCJ. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines Immunity. 2: 129-135. PMID 7895169 DOI: 10.1016/S1074-7613(95)80001-8 |
0.44 |
|
| 1995 |
Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses Journal of Virology. 69: 2004-2015. PMID 7884845 DOI: 10.1128/Jvi.69.4.2004-2015.1995 |
0.462 |
|
| 1995 |
Xiang ZQ, Spitalnik SL, Cheng J, Erikson J, Wojczyk B, Ertl HC. Immune responses to nucleic acid vaccines to rabies virus. Virology. 209: 569-79. PMID 7778289 DOI: 10.1006/Viro.1995.1289 |
0.52 |
|
| 1995 |
Yang Y, Xiang Z, Ertl HCJ, Wilson JM. Upregulation of class I major histocompatibility complex antigens by interferon γ is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo Proceedings of the National Academy of Sciences of the United States of America. 92: 7257-7261. PMID 7638177 DOI: 10.1073/Pnas.92.16.7257 |
0.432 |
|
| 1994 |
Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199: 132-40. PMID 8116236 DOI: 10.1006/viro.1994.1105 |
0.522 |
|
| 1994 |
Xiang ZQ, Ertl HCJ. A simple method to test the ability of individual viral proteins to induce immune responses Journal of Virological Methods. 47: 103-116. PMID 8051219 DOI: 10.1016/0166-0934(94)90070-1 |
0.475 |
|
| 1994 |
Yang Y, Ertl HCJ, Wilson JM. MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses Immunity. 1: 433-442. PMID 7533647 DOI: 10.1016/1074-7613(94)90074-4 |
0.44 |
|
| 1992 |
Larson JK, Wunner WH, Ertl HCJ. Immune response to the nominal phosphoprotein of rabies virus Virus Research. 23: 73-88. PMID 1534957 DOI: 10.1016/0168-1702(92)90068-K |
0.444 |
|
| 1992 |
Schumacher CL, Ertl HCJ, Koprowski H, Dietzschold B. Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens Vaccine. 10: 754-760. PMID 1441731 DOI: 10.1016/0264-410X(92)90510-Q |
0.491 |
|
| 1992 |
Xiang ZQ, Ertl HC. Transfer of maternal antibodies results in inhibition of specific immune responses in the offspring. Virus Research. 24: 297-314. PMID 1413989 DOI: 10.1016/0168-1702(92)90125-s |
0.495 |
|
| 1991 |
Zhen Fang Fu, Dietzschold B, Schumacher CL, Wunner WH, Ertl HCJ, Koprowski H. Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine Proceedings of the National Academy of Sciences of the United States of America. 88: 2001-2005. PMID 2000406 DOI: 10.1073/Pnas.88.5.2001 |
0.456 |
|
| 1990 |
Dietzschold B, Ertl HCJ. New developments in the pre- and post-exposure treatment of rabies Critical Reviews in Immunology. 10: 427-439. PMID 2021425 |
0.462 |
|
| 1990 |
Dietzschold B, Gore M, Marchadier D, Niu HS, Bunschoten HM, Otvos L, Wunner WH, Ertl HC, Osterhaus AD, Koprowski H. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. Journal of Virology. 64: 3804-3809. DOI: 10.1128/jvi.64.8.3804-3809.1990 |
0.433 |
|
| 1989 |
Schumacher CL, Dietzschold B, Ertl HCJ, Niu HS, Rupprecht CE, Koprowski H. Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies Journal of Clinical Investigation. 84: 971-975. PMID 2760222 |
0.347 |
|
| 1989 |
Ertl HCJ. Anti-idiotypic antibodies as vaccines to a murine sendai virus infection Viral Immunology. 2: 247-254. PMID 2558667 |
0.422 |
|
| 1989 |
Ertl HC, Dietzschold B, Gore M, Otvos L, Larson JK, Wunner WH, Koprowski H. Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein. Journal of Virology. 63: 2885-2892. DOI: 10.1128/jvi.63.7.2885-2892.1989 |
0.349 |
|
| 1988 |
Dietzschold B, Wang HH, Rupprecht CE, Celis E, Tollis M, Ertl H, Heber-Katz E, Koprowski H. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proceedings of the National Academy of Sciences of the United States of America. 84: 9165-9. PMID 3480536 DOI: 10.1073/Pnas.84.24.9165 |
0.529 |
|
| 1988 |
Dietzschold B, Celis E, Ertl H, Koprowski H. T and B cell antigenic determinants of ribonucleoprotein (RNP) of rabies and rabies-related viruses - their relevance in the induction of protective immunity Virus Research. 11: 65. DOI: 10.1016/0168-1702(88)90220-1 |
0.524 |
|
| 1987 |
Finberg RW, Ertl H. The use of antiidiotypic antibodies as vaccines against infectious agents Critical Reviews in Immunology. 7: 269-284. PMID 3123136 |
0.4 |
|
| 1987 |
Skinner M, Ertl HCJ, Finberg RW. Lymphokines induce specificity degradation in virus-induced cytolytic T-cell clones Cellular Immunology. 109: 159-168. PMID 3115597 DOI: 10.1016/0008-8749(87)90301-7 |
0.357 |
|
| 1986 |
Finberg RW, Ertl HCJ. Use of T cell-specific anti-idiotypes to immunize against viral infections Immunological Reviews. 129-155. PMID 3009303 DOI: 10.1111/J.1600-065X.1986.Tb01481.X |
0.385 |
|
| 1986 |
Ertl HCJ, Skinner MA, Finberg RW. Induction of anti-viral immunity by an anti-idiotypic antibody directed to a Sendai virus specific t helper cell clone International Reviews of Immunology. 1: 41-65. PMID 2855338 DOI: 10.3109/08830188609056600 |
0.378 |
|
| 1984 |
Ertl HCJ, Homans E, Tournas S, Finberg RW. Sendai virus-specific T cell clones. V. Induction of a virus-specific response by antiidiotypic antibodies directed against a T helper cell clone Journal of Experimental Medicine. 159: 1778-1783. PMID 6327875 DOI: 10.1084/Jem.159.6.1778 |
0.434 |
|
| 1984 |
Ertl HCJ, Finberg RW. Sendai virus-specific T-cell clones: Induction of cytolytic T-cells by an anti-idiotypic antibody directed against a helper T-cell clone Proceedings of the National Academy of Sciences of the United States of America. 81: 2850-2854. PMID 6326148 DOI: 10.1073/Pnas.81.9.2850 |
0.391 |
|
| 1984 |
Ertl HCJ, Finberg RW. Characteristics and functions of Sendai virus-specific T-cell clones Journal of Virology. 50: 425-431. PMID 6323742 DOI: 10.1128/Jvi.50.2.425-431.1984 |
0.403 |
|
| 1982 |
Ertl HCJ, Brown EG, Finberg RW. Sendai virus-specific T cell clones. II. Induction of interferon production by Sendai virus-specific T helper cell clones European Journal of Immunology. 12: 1051-1053. PMID 6297920 DOI: 10.1002/Eji.1830121212 |
0.348 |
|
| 1981 |
Ertl H, Ada GL. Roles of influenza virus infectivity and glycosylation of viral antigen for recognition of target cells by cytolytic T lymphocytes Immunobiology. 158: 239-253. PMID 6971249 |
0.369 |
|
| 1981 |
Ada GL, Leung KN, Ertl H. An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses Immunological Reviews. 5-24. PMID 6273293 |
0.325 |
|
| 1981 |
Ertl HCJ. Genetic and antigenic requirements for induction of T helper cells for anti-Sendai virus-specific antibody production European Journal of Immunology. 11: 541-545. PMID 6269861 |
0.404 |
|
| 1981 |
Ertl HCJ. Adoptive transfer of delayed-type hypersensitivity to Sendai virus. II. Different modes of antigen presentation determine K,D-region or I-region restriction of T cells mediating delayed-type hypersensitivity to Sendai virus Cellular Immunology. 63: 188-192. PMID 6268307 DOI: 10.1016/0008-8749(81)90039-3 |
0.337 |
|
| 1981 |
Ertl HCJ. Adoptive transfer of delayed-type hypersensitivity to Sendai virus. III. Effect of H-2 mutations on recognition by K,D-region restricted T effector lymphocytes Immunogenetics. 12: 579-586. PMID 6260639 |
0.304 |
|
| 1981 |
Ertl HCJ. Adoptive transfer of delayed-type hypersensitivity to sendai virus. I. Induction of two different subsets of T lymphocytes which differ in H-2 restriction as well as in the Lyt phenotype Cellular Immunology. 62: 38-49. PMID 6167372 DOI: 10.1016/0008-8749(81)90297-5 |
0.373 |
|
| 1981 |
Ertl HCJ. Adoptive transfer of delayed-type hypersensitivity to sendai virus - III. Effect of H-2 mutations on recognition by K, D-region restricted T effector lymphocytes Immunogenetics. 12: 579-586. DOI: 10.1007/BF01561698 |
0.333 |
|
| 1980 |
Leung K, Ashman RB, Ertl HC, Ada GL. Selective suppression of the cytotoxic T cell response to influenza virus in mice. European Journal of Immunology. 10: 803-10. PMID 6970126 DOI: 10.1002/Eji.1830101102 |
0.379 |
|
| 1977 |
Koszinowski U, Ertl H, Wekerle H, Thomssen R. Recognition of alterations induced by early vaccinia surface antigens and dependence of virus-specific lysis on H-2 antigen concentration on target cells. Cold Spring Harbor Symposia On Quantitative Biology. 41: 529-37. PMID 302176 DOI: 10.1101/Sqb.1977.041.01.061 |
0.509 |
|
| 1977 |
Koszinowski U, Ertl H. Cytotoxic interactions of virus specific effector cells with virus infected targets of different cell type Journal of Immunogenetics. 4: 107-114. PMID 194984 |
0.319 |
|
| 1977 |
Ertl HCJ, Gerike RHW, Koszinowski UH. Virus-specific T-cell sensitization - Requirements for vaccinia virus-specific T-cell sensitization in vivo Immunogenetics. 4: 515-522. DOI: 10.1007/BF01575685 |
0.377 |
|
| 1976 |
Ertl HCJ, Koszinowski UH. Modification of H2 antigenic sites by enzymatic treatment influences virus specific target cell lysis Journal of Immunology. 117: 2112-2118. PMID 993596 |
0.347 |
|
| 1976 |
Koszinowski U, Ertl H. Role of early viral surface antigens in cellular immune response to vaccinia virus European Journal of Immunology. 6: 679-683. PMID 65141 |
0.389 |
|
| 1976 |
Ertl H, Koszinowski U. Cell mediated cytotoxicity against Sendai virus infected cells Zeitschrift Fur Immunitatsforschung. 152: 128-140. PMID 60844 |
0.328 |
|
| 1975 |
Koszinowski U, Ertl H. Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus Nature. 255: 552-554. PMID 1079922 DOI: 10.1038/255552A0 |
0.447 |
|
| 1975 |
Koszinowski U, Ertl H. Altered serological and cellular reactivity to H-2 antigens after target cell infection with vaccinia virus Nature. 257: 596-597. PMID 52122 DOI: 10.1038/257596a0 |
0.319 |
|
| Show low-probability matches. |